BOULDER, Colo., July 7, 2016 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Cantor Fitzgerald 2nd Annual Healthcare Conference in New York City. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.
Event: | Cantor Fitzgerald 2nd Annual Healthcare Conference |
Presenter: | Ron Squarer, Chief Executive Officer |
Date: | Tuesday, July 12, 2016 |
Time: | 2:00 p.m. Eastern Time |
Webcast: |
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Six registration studies are currently advancing related to three cancer drugs. These programs include binimetinib (MEK162), encorafenib (LGX818) and selumetinib (AstraZeneca). For more information on Array, please go to www.arraybiopharma.com.
CONTACT: | Tricia Haugeto |
Array BioPharma Inc. | |
303-386-1193 | |
Logo - http://photos.prnewswire.com/prnh/20121029/LA02195LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-cantor-fitzgerald-2nd-annual-healthcare-conference-300295689.html
SOURCE Array BioPharma Inc.
